塩酸レボカバスチン
塩酸レボカバスチン 物理性質
- 貯蔵温度 :
- 2-8°C
- 溶解性:
- DMSO: ~10 mg/mL、可溶
- 外見 :
- 個体
- 色:
- 白い
塩酸レボカバスチン 価格
もっと(8)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01USP1359856 |
レボカバスチン塩酸塩
Levocabastine Hydrochloride |
79547-78-7 |
50mg |
￥70700 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
Y0001637 |
システム適合性2用レボカバスチン European Pharmacopoeia (EP) Reference Standard
Levocabastine for system suitability 2 European Pharmacopoeia (EP) Reference Standard |
79547-78-7 |
y0001637 |
￥19100 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
L0390000 |
レボカバスチン 塩酸塩 European Pharmacopoeia (EP) Reference Standard
Levocabastine hydrochloride European Pharmacopoeia (EP) Reference Standard |
79547-78-7 |
l0390000 |
￥24600 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
1359856 |
レボカバスチン 塩酸塩 United States Pharmacopeia (USP) Reference Standard
Levocabastine hydrochloride United States Pharmacopeia (USP) Reference Standard |
79547-78-7 |
50mg |
￥61200 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
L3042 |
レボカバスチン 塩酸塩 ≥99% (HPLC), solid
Levocabastine hydrochloride ≥99% (HPLC), solid |
79547-78-7 |
25mg |
￥119000 |
2023-06-01 |
購入 |
塩酸レボカバスチン 化学特性,用途語,生産方法
効能
抗アレルギー薬, H1受容体拮抗薬
商品名
リボスチン (ヤンセンファーマ); リボスチン (ヤンセンファーマ); リボスチン (日本新薬)
説明
Levocabastine hydrochloride is a new, highly potent and specific histamine HI-receptor
antagonist without anticholinergic or antiserotonergic side effects. It is reported to
have both a fast onset and long duration of action. Indications are the treatment of
allergic conjunctivitis and allergic rhinitis.
化学的特性
White or almost white powder.
塩酸レボカバスチン 上流と下流の製品情報
原材料
準備製品
塩酸レボカバスチン 生産企業
Global( 70)Suppliers
79547-78-7(塩酸レボカバスチン)キーワード:
- 79547-78-7
- 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride
- R50547
- LIVOSTIN
- [3s-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid
- 4-Piperidinecarboxylic acid, 1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, [3S-[1(cis),3a,4b]]-
- 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, (3S,4R)- (9CI)
- Levophta, Levostin, R50547, [3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid
- LEVOPHTA
- LEVOCABASTINE HCL
- LEVOCABASTINE HYDROCHLORIDE
- LEVOSTIN
- [3S-[1(CIS),3ALPHA,4BETA]]-1-[4-CYANO-4-(4-FLUOROPHENYL)CYCLOHEXYL]-3-METHYL-4-PHENYL-4-PIPERIDINECARBOXYLIC ACID HYDROCHLORIDE
- 4-Piperidinecarboxylic acid, 1-(cis-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (3S,4R)-
- Unii-124xma6yei
- (3S,4R)-Cabastine
- Levocabastine Hydrochloride (50 mg)
- (3S,4R)-Cabastine Hydrochloride
- Levocabastine for system suitability 2
- Levocabastine for system suitability 1 CRS
- Levocabastine hydrochloride CRS
- Levocabastine for system suitability 2 CRS
- (3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]- 3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride
- LIVOSTIN USP/EP/BP
- 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride USP/EP/BP
- Levocabastine Hydrochloride (1359856)
- 547
- (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylicacid,hydrochloride
- (3S,4R)-Cabastine HCl
- 4-Piperidinecarboxylicacid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-,hydrochloride (1:1), (3S,4R)-
- 塩酸レボカバスチン
- レボカバスチン塩酸塩
- レボカバスチン 塩酸塩
- レボカバスチン塩酸塩 (JAN)
- レボカバスチン・塩酸塩
- リボスチン
- (3S)-1-[4α-シアノ-4-(4-フルオロフェニル)シクロヘキサン-1α-イル]-3β-メチル-4-フェニルピペリジン-4α-カルボン酸・塩酸塩